Tianjin Lisheng Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Lisheng Pharmaceutical Company Limited with three other
companies in this sector in China:
Anhui Anke Biotechnology (Group) Company., Limited
sales of 849.19 million Chinese Renmimbi [US$128.14 million]
of which 57%
was Biological Products),
Zhejiang Jolly Pharmaceutical Co Ltd
(840.04 million Chinese Renmimbi [US$126.76 million]
of which 80%
was Medicinal), and
Hybio Pharmaceutical Co Ltd
(855.05 million Chinese Renmimbi [US$129.03 million]
of which 100%
was Medical and Pharmaceutical Manufacturing).
During the year ended December of 2016, sales at
Tianjin Lisheng Pharmaceutical Company Limited were 846.83 million Chinese Renmimbi (US$127.79 million).
increase of 9.3%
versus 2015, when the company's sales were 774.67 million Chinese Renmimbi.